BSE filing, NSE: ASPIRA. Summary written from the filing by ALFA Finder's alert engine.
Aspira Pathlab & Diagnostics Ltd: key numbers
- Share price
- ₹128.00
- Market cap
- ₹131.8 Cr
- Revenue (annual)
- ₹24.98 Cr
- Net profit (annual)
- ₹0.05 Cr
- P/E (TTM)
- -291.1×Sector 51.1×
- Promoter holding
- 46.65%+0.07% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aspira Pathlab & Diagnostics Ltd
All →Aspira Pathlab & Diagnostics Other Announcement
Aspira Pathlab & Diagnostics Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Listing Regulations.
Aspira Pathlab & Diagnostics Promoter Buying: ₹0.02 Cr
Promoter Jay Arvind Bhanushali acquired 1,424 equity shares of Aspira Pathlab & Diagnostics Ltd via market purchase. The transaction is valued at ₹0.02 Crore.
- Value
- ₹0.02 Cr
- Promoter stake change
- +0.01%
Aspira Pathlab & Diagnostics Promoter Buying
Promoter Jay Arvind Bhanushali acquired 1,424 shares of Aspira Pathlab & Diagnostics Ltd via the open market. This transaction increased the promoter's stake from 7.27% to 7.28%.
- Execution
- 17-09-2026 to 24-09-2026
- Promoter stake change
- +0.01%
Aspira Pathlab & Diagnostics Annual General Meeting
Aspira Pathlab & Diagnostics held its 53rd Annual General Meeting on September 25, 2026, where members deliberated on financial statements and various directorial appointments.
Aspira Pathlab & Diagnostics Promoter Buying: ₹0.01 Cr
Promoter Jay Arvind Bhanushali acquired 1,387 equity shares of Aspira Pathlab & Diagnostics Ltd through market purchase, increasing their stake from 7.25% to 7.27%.
- Value
- ₹0.01 Cr
- Promoter stake change
- +0.02%
Aspira Pathlab & Diagnostics Promoter Buying
Promoter Jay Arvind Bhanushali acquired 1,387 shares of Aspira Pathlab & Diagnostics Ltd via an open-market transaction, increasing his stake by 0.02%.
- Promoter stake change
- +0.02%
Other board meeting date announcements
All →Finelistings Technologies Board Meeting Date
Finelistings Technologies will hold a board meeting on October 31, 2026 to consider unaudited results for the half year ended September 30, 2026. The filing is a prior intimation, so no results are yet approved.
Nityas Gems and Jewellery Board Meeting Date
Nityas Gems and Jewellery intimated a board meeting on 06 Nov 2026 to consider standalone and consolidated unaudited results for the quarter and half year ended 30 Sep 2026. The meeting has not yet been held.
TCI Industries Board Meeting Date
TCI Industries will hold a board meeting on November 3, 2026 to approve unaudited results for the quarter and half year ended September 30, 2026. The trading window for designated persons remains closed until 48 hours after the results announcement.
Kalind Board Meeting Date
Kalind Ltd will hold a Board meeting on 31 October 2026 to update on and decide the ongoing preferential issue of 8,60,86,956 equity shares. In-principle approval from BSE is still awaited.
Patidar Buildcon Board Meeting Date
Patidar Buildcon will hold a board meeting on 5 November 2026 to approve unaudited Q2 results for the quarter ended 30 September 2026. The trading window stays closed until 7 November 2026.
Roopa Screen Board Meeting Date
Roopa Screen Ltd will hold a board meeting on November 2, 2026 to consider unaudited standalone results for the half year ended September 30, 2026, plus auditor appointments. The trading window closes from October 1, 2026.